Literature DB >> 10438694

The art of clinical management in pharmacologic trials with depressed elderly patients: lessons from the Pittsburgh Study of Maintenance Therapies in Late-Life Depression.

M D Miller1, E Frank, C F Reynolds.   

Abstract

The authors outline the clinical management methods used in a long-term study of depressed elderly patients and comment on the positive aspects of such interventions on the successful recruitment and retention of subjects. Psychosocial or clinical management (CM) is the "glue" that holds a successful drug trial together. CM is recognized to be an essential element for success in drug trials for geriatric depression. The authors also discuss potentially negative aspects of comprehensive CM, such as those obscuring a psychotherapeutic effect in comparative studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438694     DOI: 10.1097/00019442-199908000-00007

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  7 in total

1.  Clinic visits in late-life depression trials: effects on signal detection and therapeutic outcome.

Authors:  Bret R Rutherford; Jane Tandler; Patrick J Brown; Joel R Sneed; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2013-11-05       Impact factor: 4.105

Review 2.  Use of antidepressants in late-life depression.

Authors:  Tarek K Rajji; Benoit H Mulsant; Francis E Lotrich; Cynthia Lokker; Charles F Reynolds
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Opioid Exposure Negatively Affects Antidepressant Response to Venlafaxine in Older Adults with Chronic Low Back Pain and Depression.

Authors:  Sarah T Stahl; Changgi Jung; Debra K Weiner; Marta Peciña; Jordan F Karp
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

4.  Interpersonal psychotherapy for late-life depression: past, present, and future.

Authors:  M D Miller; C Cornes; E Frank; L Ehrenpreis; R Silberman; M A Schlernitzauer; B Tracey; V Richards; L Wolfson; J Zaltman; S Bensasi; C F Reynolds
Journal:  J Psychother Pract Res       Date:  2001

5.  Practising evidence-based medicine in an era of high placebo response: number needed to treat reconsidered.

Authors:  Steven P Roose; Bret R Rutherford; Melanie M Wall; Michael E Thase
Journal:  Br J Psychiatry       Date:  2016-05       Impact factor: 9.319

6.  Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.

Authors:  Bret R Rutherford; Timothy M Cooper; Amanda Persaud; Patrick J Brown; Joel R Sneed; Steven P Roose
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384

Review 7.  Systematic review identifies number of strategies important for retaining study participants.

Authors:  Karen A Robinson; Cheryl R Dennison; Dawn M Wayman; Peter J Pronovost; Dale M Needham
Journal:  J Clin Epidemiol       Date:  2007-05-10       Impact factor: 6.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.